BACKGROUND: Uganda has long been successful in controlling the HIV epidemic; however, there is evidence that HIV prevalence and incidence are increasing again. Data on the HIV/STI epidemic among sex workers are so far lacking from Uganda. This paper describes the baseline epidemiology of HIV/STI in a newly established cohort of women involved in high-risk sexual behavior in Kampala, Uganda. METHODS: Women were recruited from red-light areas in Kampala. Between April 2008 and May 2009, 1027 eligible women were enrolled. Sociodemographic and behavioral information were collected; blood and genital samples were tested for HIV/STI. Risk factors for HIV infection were examined using multivariate logistic regression. RESULTS: HIV seroprevalence was 37%. The prevalence of Neisseria gonorrhoeae was 13%, Chlamydia trachomatis, 9%; Trichomonas vaginalis, 17%; bacterial vaginosis, 56% and candida infection, 11%. Eighty percent had herpes simplex virus 2 antibodies (HSV-2), 21% were TPHA-positive and 10% had active syphilis (RPR+TPHA+). In 3% of the genital ulcers, Treponema pallidum (TP) was identified, Haemophilus ducreyi in 6%, and HSV-2 in 35%. Prevalent HIV was independently associated with older age, being widowed, lack of education, sex work as sole income, street-based sex work, not knowing HIV-status, using alcohol, and intravaginal cleansing with soap. HIV infection was associated with N. gonorrhoeae, T. vaginalis, bacterial vaginosis, HSV-2 seropositivity and active syphilis. CONCLUSIONS: Prevalence of HIV/STI is high among women involved in high-risk sexual behavior in Kampala. Targeted HIV prevention interventions including regular STI screening, voluntary HIV testing and counseling, condom promotion, and counseling for reducing alcohol use are urgently needed in this population.
BACKGROUND: Uganda has long been successful in controlling the HIV epidemic; however, there is evidence that HIV prevalence and incidence are increasing again. Data on the HIV/STI epidemic among sex workers are so far lacking from Uganda. This paper describes the baseline epidemiology of HIV/STI in a newly established cohort of women involved in high-risk sexual behavior in Kampala, Uganda. METHODS: Women were recruited from red-light areas in Kampala. Between April 2008 and May 2009, 1027 eligible women were enrolled. Sociodemographic and behavioral information were collected; blood and genital samples were tested for HIV/STI. Risk factors for HIV infection were examined using multivariate logistic regression. RESULTS: HIV seroprevalence was 37%. The prevalence of Neisseria gonorrhoeae was 13%, Chlamydia trachomatis, 9%; Trichomonas vaginalis, 17%; bacterial vaginosis, 56% and candida infection, 11%. Eighty percent had herpes simplex virus 2 antibodies (HSV-2), 21% were TPHA-positive and 10% had active syphilis (RPR+TPHA+). In 3% of the genital ulcers, Treponema pallidum (TP) was identified, Haemophilus ducreyi in 6%, and HSV-2 in 35%. Prevalent HIV was independently associated with older age, being widowed, lack of education, sex work as sole income, street-based sex work, not knowing HIV-status, using alcohol, and intravaginal cleansing with soap. HIV infection was associated with N. gonorrhoeae, T. vaginalis, bacterial vaginosis, HSV-2 seropositivity and active syphilis. CONCLUSIONS: Prevalence of HIV/STI is high among women involved in high-risk sexual behavior in Kampala. Targeted HIV prevention interventions including regular STI screening, voluntary HIV testing and counseling, condom promotion, and counseling for reducing alcohol use are urgently needed in this population.
Authors: Judith M Vandepitte; Faustin Malele; Dieu-Merçi Kivuvu; Samuel Edidi; Jérémie Muwonga; François Lepira; Said Abdellati; Joelle Kabamba; Catherine Van Overloop; Anne Buvé Journal: Sex Transm Dis Date: 2007-04 Impact factor: 2.830
Authors: Saidi H Kapiga; Noel E Sam; John F Shao; Boris Renjifo; Elisante J Masenga; Ireen E Kiwelu; Rachel Manongi; Wafaie Fawzi; Max Essex Journal: J Acquir Immune Defic Syndr Date: 2002-04-01 Impact factor: 3.731
Authors: Michel Alary; Léonard Mukenge-Tshibaka; France Bernier; Nassirou Geraldo; Catherine M Lowndes; Honoré Meda; Cyriaque A B Gnintoungbè; Séverin Anagonou; Jean R Joly Journal: AIDS Date: 2002-02-15 Impact factor: 4.177
Authors: P D Ghys; M O Diallo; V Ettiègne-Traoré; K M Yeboué; E Gnaoré; F Lorougnon; K Kalé; E Van Dyck; K Brettegaard; Y M Hoyi Journal: J Infect Dis Date: 1995-11 Impact factor: 5.226
Authors: N Nzila; M Laga; M A Thiam; K Mayimona; B Edidi; E Van Dyck; F Behets; S Hassig; A Nelson; K Mokwa Journal: AIDS Date: 1991-06 Impact factor: 4.177
Authors: Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen Journal: Afr Health Sci Date: 2014-12 Impact factor: 0.927
Authors: Kate Shannon; Steffanie A Strathdee; Shira M Goldenberg; Putu Duff; Peninah Mwangi; Maia Rusakova; Sushena Reza-Paul; Joseph Lau; Kathleen Deering; Michael R Pickles; Marie-Claude Boily Journal: Lancet Date: 2014-07-22 Impact factor: 79.321
Authors: Andrew D Redd; Deogratius Ssemwanga; Judith Vandepitte; Sarah K Wendel; Nicaise Ndembi; Justine Bukenya; Susan Nakubulwa; Heiner Grosskurth; Chris M Parry; Craig Martens; Daniel Bruno; Stephen F Porcella; Thomas C Quinn; Pontiano Kaleebu Journal: AIDS Date: 2014-09-10 Impact factor: 4.177
Authors: Rosanna W Peeling; David Mabey; Mary L Kamb; Xiang-Sheng Chen; Justin D Radolf; Adele S Benzaken Journal: Nat Rev Dis Primers Date: 2017-10-12 Impact factor: 52.329
Authors: Lucie Abeler-Dörner; Mary K Grabowski; Andrew Rambaut; Deenan Pillay; Christophe Fraser Journal: Curr Opin HIV AIDS Date: 2019-05 Impact factor: 4.283
Authors: Judith Vandepitte; Helen A Weiss; Nassim Kyakuwa; Susan Nakubulwa; Etienne Muller; Anne Buvé; Patrick Van der Stuyft; Richard Hayes; Heiner Grosskurth Journal: Sex Transm Dis Date: 2013-05 Impact factor: 2.830
Authors: Emily Mabonga; Yukari C Manabe; Ali Elbireer; Joshua K Mbazira; Maria S Nabaggala; Agnes Kiragga; Jennifer Kisakye; Charlotte A Gaydos; Chris Taylor; Rosalind Parkes-Ratanshi Journal: Int J STD AIDS Date: 2021-02-20 Impact factor: 1.359